Determination of HER2 and p53 Mutations by Sequence Analysis Method and EGFR/Chromosome 7 Gene Status by Fluorescence in Situ Hybridization for the Predilection of Targeted Therapy Modalities in Immunohistochemically Triple Negative Breast Carcinoma
about
Determination of HER2 and p53 Mutations by Sequence Analysis Method and EGFR/Chromosome 7 Gene Status by Fluorescence in Situ Hybridization for the Predilection of Targeted Therapy Modalities in Immunohistochemically Triple Negative Breast Carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@en
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@nl
type
label
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@en
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@nl
prefLabel
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@en
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@nl
P2093
P2860
P1476
Determination of HER2 and p53 ...... iple Negative Breast Carcinoma
@en
P2093
Alp Ozguzer
Elif Usturali Keskin
Emel Ebru Pala
Ulku Kucuk
Umit Bayol
P2860
P2888
P304
P356
10.1007/S12253-015-9956-1
P577
2015-06-10T00:00:00Z